Rapamycin: Something Old, Something New, Sometimes Borrowed and Now Renewed von Hartford, C M, Ratain, M J

Volltext

Food Effect Studies for Oncology Drug Products von Parsad, S, Ratain, MJ

Volltext

Pharmacogenetics and pharmacogenomics of anticancer agents von Huang, R. Stephanie, Ratain, Mark J

Volltext

Potential for value-based prescribing of oral oncology drugs von Ratain, M.J., Lichter, A.S.

Volltext

Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial von Nakamura, Yusuke, Ratain, Mark J, Cox, Nancy J, McLeod, Howard L, Kroetz, Deanna L, Flockhart, David A

Volltext

Meaningful Use of Pharmacogenetics von Ratain, M J, Johnson, J A

Volltext

ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia von Li, M, Seiser, E L, Baldwin, R M, Ramirez, J, Ratain, M J, Innocenti, F, Kroetz, D L

Volltext

Randomized Phase II Trials: A Long-term Investment With Promising Returns von Sharma, Manish R., Stadler, Walter M., Ratain, Mark J.

Volltext

Are Drug Labels Static or Dynamic? von Seminerio, M J, Ratain, M J

Volltext

Genome-wide association studies of drug response and toxicity: an opportunity for genome medicine von Giacomini, Kathleen M., Yee, Sook Wah, Mushiroda, Taisei, Weinshilboum, Richard M., Ratain, Mark J., Kubo, Michiaki

Volltext

CYP2D6 Genotype and Tamoxifen Activity: Understanding Interstudy Variability in Methodological Quality von Ratain, M J, Nakamura, Y, Cox, N J

Volltext

Impact and applicability of pharmacogenomics in rheumatology: an integrated analysis von Reid, Pankti, Danahey, Keith, Lopez Velazquez, Marco, Ratain, Mark J, O'Donnell, Peter H

Volltext

Pharmacogenetics in Cancer Treatment von Nagasubramanian, R, Innocenti, F, Ratain, M. J

Volltext

Pharmacogenetic Pathway Analysis of Irinotecan von Rosner, GL, Panetta, JC, Innocenti, F, Ratain, MJ

Volltext

The Outlier in All of Us: Why Implementing Pharmacogenomics Could Matter for Everyone von O'Donnell, PH, Danahey, K, Ratain, MJ

Volltext

Update on pharmacogenetics in cancer chemotherapy von Innocenti, F., Ratain, M.J.

Volltext

Models of Excellence: Improving Oncology Drug Development von Sharma, M R, Maitland, M L, Ratain, M J

Volltext

Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non–Small-Cell Lung Cancer von Karrison, Theodore G., Maitland, Michael L., Stadler, Walter M., Ratain, Mark J.

Volltext

Playing Russian Roulette With Tyrosine Kinase Inhibitors von Szmulewitz, R Z, Ratain, M J

Volltext

Body-surface area as a basis for dosing of anticancer agents: science, myth, or habit? von Ratain, M J

Volltext